BSE Live
Dec 24, 16:01Prev. Close
412.85
Open Price
410.95
Bid Price (Qty.)
424.45 (1)
Offer Price (Qty.)
424.45 (291)
NSE Live
Dec 24, 14:52Prev. Close
412.35
Open Price
410.00
Bid Price (Qty.)
420.75 (32)
Offer Price (Qty.)
421.00 (134)
| Key Financial Ratios of Aarti Drugs (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 32.04 | 50.97 | 37.36 | 17.84 | 18.56 | |
| Diluted EPS (Rs.) | 32.04 | 50.97 | 37.36 | 17.84 | 18.56 | |
| Cash EPS (Rs.) | 44.71 | 74.19 | 58.82 | 38.55 | 33.21 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 125.41 | 207.21 | 171.46 | 145.75 | 129.26 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 125.41 | 207.21 | 171.46 | 145.75 | 129.26 | |
| Dividend / Share(Rs.) | 13.00 | 13.00 | 10.00 | 5.00 | 5.00 | |
| Revenue from Operations/Share (Rs.) | 448.95 | 802.52 | 681.95 | 549.50 | 410.04 | |
| PBDIT/Share (Rs.) | 70.04 | 120.88 | 99.38 | 66.29 | 51.77 | |
| PBIT/Share (Rs.) | 57.37 | 97.66 | 77.92 | 46.29 | 37.12 | |
| PBT/Share (Rs.) | 41.32 | 70.00 | 54.41 | 26.61 | 25.99 | |
| Net Profit/Share (Rs.) | 32.04 | 50.97 | 37.36 | 18.55 | 18.56 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 15.59 | 15.06 | 14.57 | 12.06 | 12.62 | |
| PBIT Margin (%) | 12.77 | 12.16 | 11.42 | 8.42 | 9.05 | |
| PBT Margin (%) | 9.20 | 8.72 | 7.97 | 4.84 | 6.33 | |
| Net Profit Margin (%) | 7.13 | 6.35 | 5.47 | 3.37 | 4.52 | |
| Return on Networth / Equity (%) | 25.55 | 24.59 | 21.79 | 12.72 | 14.35 | |
| Return on Capital Employed (%) | 15.44 | 16.67 | 13.76 | 8.15 | 8.61 | |
| Return on Assets (%) | 8.02 | 7.26 | 6.28 | 3.66 | 4.35 | |
| Total Debt/Equity (X) | 1.33 | 1.36 | 1.42 | 1.54 | 1.42 | |
| Asset Turnover Ratio (%) | 112.44 | 114.35 | 114.73 | 108.60 | 96.24 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.09 | 0.95 | 1.04 | 0.97 | 0.97 | |
| Quick Ratio (X) | 0.76 | 0.69 | 0.68 | 0.68 | 0.65 | |
| Inventory Turnover Ratio (X) | 7.09 | 7.67 | 5.86 | 6.80 | 5.97 | |
| Dividend Payout Ratio (NP) (%) | 24.96 | 25.50 | 26.74 | 26.95 | 26.94 | |
| Dividend Payout Ratio (CP) (%) | 17.89 | 17.52 | 16.98 | 12.97 | 15.05 | |
| Earnings Retention Ratio (%) | 75.04 | 74.50 | 73.26 | 73.05 | 73.06 | |
| Cash Earnings Retention Ratio (%) | 82.11 | 82.48 | 83.02 | 87.03 | 84.95 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 1,977.66 | 656.78 | 466.26 | 390.88 | 372.97 | |
| EV/Net Operating Revenue (X) | 1.82 | 0.68 | 0.56 | 0.59 | 0.75 | |
| EV/EBITDA (X) | 11.66 | 4.49 | 3.87 | 4.87 | 5.95 | |
| MarketCap/Net Operating Revenue (X) | 1.45 | 0.33 | 0.21 | 0.19 | 0.31 | |
| Retention Ratios (%) | 75.03 | 74.49 | 73.25 | 73.04 | 73.05 | |
| Price/BV (X) | 5.20 | 1.27 | 0.84 | 0.70 | 0.99 | |
| Price/Net Operating Revenue | 1.45 | 0.33 | 0.21 | 0.19 | 0.31 | |
| Earnings Yield | 0.05 | 0.19 | 0.26 | 0.18 | 0.14 |
14.11.2025
Aarti Drugs Consolidated September 2025 Net Sales at Rs 652.79 crore, up 9.1% Y-o-Y
12.11.2025
Aarti Drugs Standalone September 2025 Net Sales at Rs 578.95 crore, up 6.6% Y-o-Y
18.07.2025
Aarti Drugs Standalone June 2025 Net Sales at Rs 520.96 crore, up 5.68% Y-o-Y
18.07.2025
Aarti Drugs Consolidated June 2025 Net Sales at Rs 590.51 crore, up 6.33% Y-o-Y